منابع مشابه
Pantoprazole may enhance antiplatelet effect of enteric-coated aspirin in patients with acute coronary syndrome.
BACKGROUND Antiplatelet therapy has proven beneficial in the treatment of cardiovascular disease. Proton pump inhibitors (PPIs) are commonly used for gastroprotection in patients receiving antiplatelet therapy. Several trials have been carried out to establish interactions between PPIs, clopidogrel and soluble formulations of aspirin, but no studies with PPIs and enteric-coated (EC) forms of as...
متن کاملVariability in platelet response to a single daily dose of 150 mg enteric coated aspirin in a high risk population.
PURPOSE Previous studies have reported inadequate anti-platelet effect in 0.4-35% of patients taking aspirin. Such studies have arbitrarily defined the terms "semi-responders", "non-responders" or "resistant" to variable doses of aspirin on the basis of absolute values derived from different ex-vivo platelet aggregation (PA) methods. Our objective was to define response to 150-mg dose of aspiri...
متن کاملEnteric-coated Potassium Chloride
value and -therefore any improvement in homoeossatic control would have been obvious during pregnancy. Thus our argument that the shape of the curve may be a more importa indicator of homoeostatc control than any actual level reached appears to be supported by these cases. It is probable that factors controlling fasting blood glucose concentrations are separate from those affecting homoeostatic...
متن کاملRisk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations
BACKGROUND The use of low-dose aspirin has been reported to be associated with an increased risk of upper gastrointestinal complications (UGIC). The coating of aspirin has been proposed as an approach to reduce such a risk. To test this hypothesis, we carried out a population based case-control study. METHODS We identified incident cases of UGIC (bleeding or perforation) aged 40 to 79 years b...
متن کاملRisk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations
Background: The use of low-dose aspirin has been reported to be associated with an increased risk of upper gastrointestinal complications (UGIC). The coating of aspirin has been proposed as an approach to reduce such a risk. To test this hypothesis, we carried out a population based casecontrol study. Methods: We identified incident cases of UGIC (bleeding or perforation) aged 40 to 79 years be...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1995
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.311.7001.391c